About this episode
Finn Haley, SVP, Corporate Development at Edwards Lifesciences (NYSE:EW)
This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom.
To join our growing online community of M&A practitioners, visit https://www.mascience.com/academy. Don't forget to use code "podcast" at checkout.
Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at https://www.dealroom.net
FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to https://www.firmroom.com
Episode Timestamps
00:00 Intro
08:53 Option structure
14:04 Exit cap
16:11 Drivers for the structure
18:28 Alignment with the strategy
20:35 Monitoring progress and milestones
22:16 Moving fast
24:08 Failed startups
26:16 Risks
30:09 Exercising the option
33:54 Why deals don't push through
38:53 Innovation
40:13 Approaching a company for the buy-to-build option structure
43:20 Craziest thing in M&A
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science
Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science
Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science
Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science
Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science